Wegovy Self-Pay Program - Injectable

Funded

About

For patients without insurance or whose insurance does not cover Wegovy injection. Standard self-pay price is $349 per month for all dose strengths through NovoCare Pharmacy. New patients can get introductory pricing of $199/month for the first 2 fills of 0.25 mg and 0.5 mg doses (available through March 31, 2026). Government beneficiaries are not eligible.

Insurance requirements: Uninsured

As low as: $349 per mo

Enrollment Forms

Wegovy Self-Pay Pricing

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Must be 18 years of age or older

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Standard selfpay price: $349 per month (1 box) for all Wegovy injection dose strengths

•Limitedtime introductory offer: $199 per month for first 2 fills of 0.25 mg and 0.5 mg doses (Nov 17, 2025 March 31, 2026)

•Multimonth pricing: $698 for 2 months, $1,047 for 3 months

•Available through NovoCare Pharmacy

•No insurance or income requirements

•Government program beneficiaries are not eligible for selfpay pricing

•Commercially insured patients may opt to selfpay instead of using insurance

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Enrollment Forms

Wegovy Self-Pay Pricing

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Frequently Asked Questions (FAQ)

The Wegovy Savings Offer from Novo Nordisk lets eligible commercially insured patients pay as little as $25 per month, with savings up to $100 per month. Patients with Medicare or Medicaid coverage can't use the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH programs (Wegovy at no cost, eligibility-dependent). Open the program cards above for the option that matches your patient.

Yes — the Wegovy Savings Offer from Novo Nordisk. Eligible patients with commercial insurance pay as little as $25 per month, up to $100 per month in savings. Patients on Medicare or Medicaid aren't eligible for the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH program (Wegovy at no cost for eligible patients). See the program cards above for current terms.

PrescriberPoint surfaces Novo Nordisk's self-pay options for uninsured patients: the Wegovy Self-Pay Program for the oral tablet is as low as $149 per month, and the injectable self-pay program is as low as $349 per month. Commercially insured patients can use the Wegovy Savings Offer instead — as little as $25 per month, up to $100 per month in savings. Open the program cards above to compare every option for your patient.

There are paths for every coverage type. Commercially insured patients → Wegovy Savings Offer ($25/month, up to $100/month in savings). Medicare or Medicaid patients → HealthWell Foundation MASH or PAN Foundation MASH (no cost for eligible patients). Uninsured patients → Wegovy Self-Pay Program ($149/month oral tablet, $349/month injectable). The program cards above show each option with its eligibility and enrollment link.